Liénard D - Search Results

1

Increased serum alpha-melanocyte stimulating hormone (alpha-MSH) in human malignant melanoma.

Ghanem G, Liénard D, Hanson P, Lejeune F, Frühling J. Ghanem G, et al. Among authors: lienard d. Eur J Cancer Clin Oncol. 1986 Apr;22(4):535-6. doi: 10.1016/0277-5379(86)90125-2. Eur J Cancer Clin Oncol. 1986. PMID: 3732358 No abstract available.

2

Regional therapy of melanoma.

Lejeune FJ, Liénard D, Leyvraz S, Mirimanoff RO. Lejeune FJ, et al. Among authors: lienard d. Eur J Cancer. 1993;29A(4):606-12. doi: 10.1016/s0959-8049(05)80163-7. Eur J Cancer. 1993. PMID: 8435217 Review.

3

On the release and half-life of S100B protein in the peripheral blood of melanoma patients.

Ghanem G, Loir B, Morandini R, Sales F, Lienard D, Eggermont A, Lejeune F; EORTC Melanoma Group. Ghanem G, et al. Among authors: lienard d. Int J Cancer. 2001 Nov;94(4):586-90. doi: 10.1002/ijc.1504. Int J Cancer. 2001. PMID: 11745448

4

Results of 206 isolated limb perfusions for malignant melanoma.

Lejeune FJ, Liénard D, el Douaihy M, Seyedi JV, Ewalenko P. Lejeune FJ, et al. Among authors: lienard d. Eur J Surg Oncol. 1989 Dec;15(6):510-9. Eur J Surg Oncol. 1989. PMID: 2599121

5

Therapeutic value of scapular and pelvic girdle disarticulations in sarcoma.

Lienard D, Lejeune FJ. Lienard D, et al. Eur J Surg Oncol. 1987 Jun;13(3):231-7. Eur J Surg Oncol. 1987. PMID: 3595886

6

TNF alpha: shock-free cancer remission.

Lejeune FJ, Liénard D. Lejeune FJ, et al. Among authors: lienard d. Nat Biotechnol. 1996 Jun;14(6):706, 708. doi: 10.1038/nbt0696-706. Nat Biotechnol. 1996. PMID: 9630973 No abstract available.

7

Early endothelium activation and polymorphonuclear cell invasion precede specific necrosis of human melanoma and sarcoma treated by intravascular high-dose tumour necrosis factor alpha (rTNF alpha).

Renard N, Liénard D, Lespagnard L, Eggermont A, Heimann R, Lejeune F. Renard N, et al. Among authors: lienard d. Int J Cancer. 1994 Jun 1;57(5):656-63. doi: 10.1002/ijc.2910570508. Int J Cancer. 1994. PMID: 8194873 Clinical Trial.

8

High-dose recombinant tumor necrosis factor alpha in combination with interferon gamma and melphalan in isolation perfusion of the limbs for melanoma and sarcoma.

Lienard D, Ewalenko P, Delmotte JJ, Renard N, Lejeune FJ. Lienard D, et al. J Clin Oncol. 1992 Jan;10(1):52-60. doi: 10.1200/JCO.1992.10.1.52. J Clin Oncol. 1992. PMID: 1727926 Clinical Trial.

9

High serum levels of TNF-alpha after its administration for isolation perfusion of the limb.

Gérain J, Liénard D, Ewalenko P, Lejeune FJ. Gérain J, et al. Among authors: lienard d. Cytokine. 1992 Nov;4(6):585-91. doi: 10.1016/1043-4666(92)90024-l. Cytokine. 1992. PMID: 1292642 Clinical Trial.

10

Surgical management of distant melanoma metastases.

Lejeune FJ, Liénard D, Sales F, Badr-el-Din H. Lejeune FJ, et al. Among authors: lienard d. Semin Surg Oncol. 1992 Nov-Dec;8(6):381-91. doi: 10.1002/ssu.2980080609. Semin Surg Oncol. 1992. PMID: 1439449 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

155 results

Search Page

Filters